Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 7/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | APAF1 | O14727 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL29396207 | 1.00 | KCNH2 (0.50) | KCNH2KDM4EAPAF1ALDH1A1LMNA | |
| Trifluoromethanesulfonic Acid SCHEMBL30329835 | 0.96 | KCNH2 (0.52) | KCNH2LMNARAD52 | |
| Trifluoromethanesulfonic Acid SCHEMBL30212841 | 0.96 | KCNH2 (0.52) | KCNH2LMNARAD52 | |
| Trifluoromethanesulfonic Acid SCHEMBL30212901 | 0.96 | KCNH2 (0.52) | KCNH2LMNARAD52 | |
| Trifluoromethanesulfonic Acid SCHEMBL23004140 | 0.96 | KCNH2 (0.52) | KCNH2LMNARAD52 | |
| Trifluoromethanesulfonic Acid SCHEMBL23004225 | 0.96 | KCNH2 (0.52) | KCNH2LMNARAD52 | |
| Trifluoromethanesulfonic Acid SCHEMBL23004387 | 0.96 | KCNH2 (0.52) | KCNH2LMNARAD52 | |
| Trifluoromethanesulfonic Acid SCHEMBL23004549 | 0.96 | KCNH2 (0.52) | KCNH2LMNARAD52 | |
| Trifluoromethanesulfonic Acid SCHEMBL14990400 | 0.96 | KCNH2 (0.52) | KCNH2LMNARAD52 | |
| Trifluoromethanesulfonic Acid SCHEMBL28251929 | 0.96 | KCNH2 (0.52) | KCNH2LMNARAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 371 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210395906-A1 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | CUSTOMARRAY INC (US) | 2021-12-23 | — | — | US | claimed |
| CN-107847867-B | Composite membranes having improved performance and/or durability and methods of use thereof | 3M创新有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-107427758-B | Separation using ionic liquid solvents | 切弗朗菲利浦化学公司 | 2020-11-20 | — | — | CN | claimed |
| US-20200164319-A1 | COMPOSITE MEMBRANES WITH IMPROVED PERFORMANCE AND/OR DURABILITY AND METHODS OF USE | 3M INNOVATIVE PROPERTIES COMPANY | 2020-05-28 | — | — | US | claimed |
| US-20200030748-A1 | COMPOSITE MEMBRANES WITH IMPROVED PERFORMANCE AND/OR DURABILITY AND METHODS OF USE | 3M INNOVATIVE PROPERTIES COMPANY | 2020-01-30 | — | — | US | claimed |
| US-10478778-B2 | Composite membranes with improved performance and/or durability and methods of use | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-11-19 | — | — | US | claimed |
| US-20180154311-A1 | COMPOSITE MEMBRANES WITH IMPROVED PERFORMANCE AND/OR DURABILITY AND METHODS OF USE | 3M INNOVATIVE PROPERTIES COMPANY | 2018-06-07 | — | — | US | claimed |
| US-20150133711-A1 | Separations With Ionic Liquid Solvents | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2015-05-14 | — | — | US | claimed |
| EP-1658268-B1 | MIXTURES OF IONIC LIQUIDS WITH LEWIS ACIDS | NOVARTIS AG (CH) | 2014-02-12 | — | — | EP | claimed |
| US-20130341561-A1 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | CUSTOMARRAY, INC. (US) | 2013-12-26 | — | — | US | claimed |
| EP-1869061-A2 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | Combimatrix Corporation (US) | 2007-12-26 | — | — | EP | claimed |
| EP-1805206-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | Combimatrix Corporation (US) | 2007-07-11 | — | — | EP | claimed |
| US-20070034513-A1 | Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array | COMBIMATRIX CORPORATION | 2007-02-15 | — | — | US | claimed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | claimed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | claimed |
| WO-2006105037-A2 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | COMBIMATRIX CORPORATION (US) | 2006-10-05 | — | — | WO | claimed |
| WO-2006031814-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | COMBIMATRIX CORPORATION (US) | 2006-03-23 | — | — | WO | claimed |
| US-20060054511-A1 | Electrochemical deblocking using a hydrazine derivative | CUSTOMARRAY, INC. | 2006-03-16 | — | — | US | claimed |
| US-20050150383-A1 | Facilitated transport membranes for an alkene Hydrocarbon separation | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY | 2005-07-14 | — | — | US | claimed |
| EP-1552875-A1 | Facilitated transport membranes for an alkene hydrocarbon separation | Korea Institute of Science and Technology (KR) | 2005-07-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395906-A1 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | DNMT1, DNASE1, DNPEP | KCNH2 484/4885KDM4E 4183/4885APAF1 1113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.